Flow Imaging Microscopy Market Trends
The global flow imaging microscopy market size was valued at USD 41.64 million in 2023 and is projected to grow at a CAGR of 7.31% from 2024 to 2030. Factors contributing to the growth include technological advancements, increasing applications across various industries, rising demand for automated imaging solutions, and the growing focus on research and development activities. For instance in April 2023, Nikon Corporation introduced the ECLIPSE Ui digital imaging microscope for medical use in Japan through its subsidiary, Nikon Solutions Co., Ltd. This innovative microscope lacks an eyepiece lens, enhancing pathologists' comfort and enabling image sharing on displays, streamlining pathological observation processes.
Advancements in imaging technology, such as the integration of artificial intelligence and machine learning algorithms, significantly enhanced the capabilities of flow imaging microscopy systems. These technological advancements improved image quality, higher throughput, and enhanced data analysis capabilities. For instance, in October 2023, Olympus unveiled the FV4000MPE multiphoton and FLUOVIEW FV4000 confocal laser scanning microscopes, which comprise advancements in imaging technology. These microscopes bear reduced noise, higher precision, and improved sensitivity, setting a new standard for scientific imaging and enabling researchers to make novel discoveries.
The shift towards personalized medicine has led to growing demand for flow imaging microscopy among researchers. As customized medicine gains prominence in healthcare, there is a growing need for advanced imaging techniques that can provide detailed insights into individual patient characteristics at a cellular level. Flow imaging microscopy enables researchers and clinicians to rapidly analyse cell populations, supporting personalized treatment strategies based on specific patient profiles.
Global Flow Imaging Microscopy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global flow imaging microscopy market report on the basis of technology, sample type, end-use, and region.
- Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Dynamic Image Analysis
- Static Image Analysis
- Combination System
- Sample Outlook (Revenue, USD Million, 2018 - 2030)
- Large Molecule
- Small Molecule
- Liquid Sample
- Other Samples
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Biotechnology and Life Science
- Pharmaceutical
- Material Science
- Environmental
- Food and Beverage
- Cosmetics and Personal Care
- Regional Outlook (Revenue in USD Million, 2018 - 2030)
- North America
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Technology
- 1.2.2. Sample
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Technology outlook
- 2.2.2. Sample outlook
- 2.2.3. End Use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Flow Imaging Microscopy Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increased investments in pharmaceutical research
- 3.2.1.2. Regulatory guidelines for Technology quality
- 3.2.1.3. Technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. Technological limitations
- 3.3. Flow Imaging Microscopy Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
Chapter 4. Flow Imaging Microscopy Market: Technology Estimates & Trend Analysis
- 4.1. Technology Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Flow Imaging Microscopy Market by Technology Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Dynamic image analysis
- 4.4.1.1. Dynamic image analysis market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Static Image Analysis
- 4.4.2.1. Static image analysis market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Combination System
- 4.4.3.1. Combination System market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Flow Imaging Microscopy Market: Sample Estimates & Trend Analysis
- 5.1. Global Flow Imaging Microscopy Market: Sample Dashboard
- 5.2. Global Flow Imaging Microscopy Market: Sample Movement Analysis
- 5.3. Global Flow Imaging Microscopy Market by Treatment, Revenue
- 5.4. Large Molecule
- 5.4.1. Large Molecule market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Small Molecule
- 5.5.1. Small Molecule market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Liquid Sample
- 5.6.1. Liquid Sample market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Other Samples
- 5.7.1. Other Samples market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Flow Imaging Microscopy Market: End Use Estimates & Trend Analysis
- 6.1. End Use Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Flow Imaging Microscopy Market by End Use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Biotechnology and Life Science
- 6.4.1.1. Biotechnology and life science market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Pharmaceutical
- 6.4.2.1. Pharmaceutical market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Material Science
- 6.4.3.1. Material Science market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Environmental
- 6.4.4.1. Environmental market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Food and Beverage
- 6.4.5.1. Food and Beverage market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Cosmetics and Personal Care
- 6.4.6.1. Cosmetics and Personal Care market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Flow Imaging Microscopy Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. North America
- 7.5.2. U.S.
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe
- 7.6.2. UK
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ Reimbursement
- 7.6.2.3. Competitive scenario
- 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ Reimbursement
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ Reimbursement
- 7.6.4.3. Competitive scenario
- 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework/ Reimbursement
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Denmark
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework/ Reimbursement
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.9. Norway
- 7.6.9.1. Key country dynamics
- 7.6.9.2. Regulatory framework
- 7.6.9.3. Competitive scenario
- 7.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific
- 7.7.2. Japan
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ Reimbursement
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ Reimbursement
- 7.7.3.3. Competitive scenario
- 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ Reimbursement
- 7.7.4.3. Competitive scenario
- 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. Australia
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ Reimbursement
- 7.7.5.3. Competitive scenario
- 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. South Korea
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework/ Reimbursement
- 7.7.6.3. Competitive scenario
- 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key country dynamics
- 7.7.7.2. Regulatory framework/ Reimbursement
- 7.7.7.3. Competitive scenario
- 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America
- 7.8.2. Brazil
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework/ Reimbursement
- 7.8.3.3. Competitive scenario
- 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. MEA
- 7.9.2. South Africa
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework/ Reimbursement
- 7.9.2.3. Competitive scenario
- 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework/ Reimbursement
- 7.9.3.3. Competitive scenario
- 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework/ Reimbursement
- 7.9.4.3. Competitive scenario
- 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key country dynamics
- 7.9.5.2. Regulatory framework
- 7.9.5.3. Competitive scenario
- 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Profiles
- 8.1.1. Bettersize Instruments
- 8.1.1.1. Company overview
- 8.1.1.2. Financial performance
- 8.1.1.3. Product benchmarking
- 8.1.1.4. Strategic initiatives
- 8.1.2. Bio-Techne
- 8.1.2.1. Company overview
- 8.1.2.2. Financial performance
- 8.1.2.3. Product benchmarking
- 8.1.2.4. Strategic initiatives
- 8.1.3. Anton Paar
- 8.1.3.1. Company overview
- 8.1.3.2. Financial performance
- 8.1.3.3. Product benchmarking
- 8.1.3.4. Strategic initiatives
- 8.1.4. Yokogawa Electric Corporation
- 8.1.4.1. Company overview
- 8.1.4.2. Financial performance
- 8.1.4.3. Product benchmarking
- 8.1.4.4. Strategic initiatives
- 8.1.5. Microtrac MRB
- 8.1.5.1. Company overview
- 8.1.5.2. Financial performance
- 8.1.5.3. Product benchmarking
- 8.1.5.4. Strategic initiatives
- 8.1.6. Micromeritics Instrument Corporation
- 8.1.6.1. Company overview
- 8.1.6.2. Financial performance
- 8.1.6.3. Product benchmarking
- 8.1.6.4. Strategic initiatives
- 8.1.7. Fritsch
- 8.1.7.1. Company overview
- 8.1.7.2. Financial performance
- 8.1.7.3. Product benchmarking
- 8.1.7.4. Strategic initiatives
- 8.1.8. Haver & Boecker
- 8.1.8.1. Company overview
- 8.1.8.2. Financial performance
- 8.1.8.3. Product benchmarking
- 8.1.8.4. Strategic initiatives
- 8.1.9. Spectris
- 8.1.9.1. Company overview
- 8.1.9.2. Financial performance
- 8.1.9.3. Product benchmarking
- 8.1.9.4. Strategic initiatives
- 8.1.10. HORIBA
- 8.1.10.1. Company overview
- 8.1.10.2. Financial performance
- 8.1.10.3. Product benchmarking
- 8.1.10.4. Strategic initiatives
- 8.2. Company Market Position Analysis
- 8.3. Company/Competition Categorization
- 8.4. Strategy Mapping